PharmaEngine
4162.TWO
2.63 USD
0.00
0.00%
p
Overview
Last close
2.63 usd
Market cap
372.28M usd
52 week high
3.68 usd
52 week low
2.32 usd
Target price
4.08 usd
Valuation
P/E
6.2713
Forward P/E
N/A
Price/Sales
4.3012
Price/Book Value
1.9878
Enterprise Value
179.54M usd
EV/Revenue
2.0724
EV/EBITDA
2.4011
Key financials
Revenue TTM
86.64M usd
Gross Profit TTM
84.97M usd
EBITDA TTM
70.65M usd
Earnings per Share
0.42 usd
Dividend
0.2 usd
Total assets
179.19M usd
Net debt
N/A usd
About
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells. The company is developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.
- Symbol4162.TWO
- ExchangeTWO
- IsinTW0004162003
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CEOMr. Hong-Ren Wang Ph.D.
- HeadquarterTaipei
- Web sitehttps://www.pharmaengine.com
